66 次浏览 · 92 次下载 · ☆☆☆☆☆ 0.0

BNN27 nanoformulations for nose-to-brain delivery

发表日期 June 21, 2023 (DOI: https://doi.org/10.54985/peeref.2306p3373108)

未经同行评议

作者

Maria Kannavou1 , Kanelina Karali2 , Theodora Katsila3 , Eleni Siapi3 , Antonia Marazioti1 , Pavlos Klepetsanis1 , Theodora Calogeropoulou3 , Ioannis Charalampopoulos2 , Sophia G. Antimisiaris1
  1. University of Patras and FORTH/ICE-HT
  2. University of Crete and IMBB/FORTH
  3. Institute of Chemical Biology, National Hellenic Research Foundation

会议/活动

6th Nanomed Workshop, July 2023 (Patras, Greece)

海报摘要

Intranasal administration offers an alternative way for brain targeting. In this project, we studied the design of two innovative mucoadhesive nanoformulations for BNN27 intranasal delivery. Negatively-charged and uncharged liposomes were coated with chitosan (CHT) at different CHT/lipid ratios. Medium MW CHT-coated PC/PG/BNN27 liposomes at 0.1w/w CHT/lipid ratio demonstrated highest coating efficiency & mucoadhesive properties. Furthermore, preparation of mucoadhesive nanoemulsions (MNEs) was studied. NEs were prepared by the spontaneous emulsification method using Capmul MCM as oily phase. MNEs with 10%w/w Capmul MCM and 0.3%w/w CHT, displayed optimal physicochemical characteristics. Optimal nanoformulations were evaluated for their permeability across a cellular BBB model (hCMEC/D3 cell monolayers) in vitro. Also, their in vivo fate after intranasal administration revealed the superiority of CHT-NEs for more efficient BNN27 distribution to the brain, compared to CHT-LIPs. Current results prove that CHT-NEs succeed to deliver more BNN27 to the brain (and faster), compared to CHT-coated LIPs.

关键词

BNN27, Mucoadhesive nanoformulations, Intranasal delivery

研究领域

Pharmacy and Pharmacology

参考文献

  1. Gravanis, A.; Pediaditakis, I.; Charalampopoulos, I. Synthetic Microneurotrophins in Therapeutics of Neurodegeneration. Oncotarget 2017, 8, 9005–9006
  2. Kannavou, M.; Karali, K.; Katsila, T.; Siapi, E.; Marazioti, A.; Klepetsanis, P.; Calogeropoulou, T.; Charalampopoulos, I.; Antimisiaris, S.G. Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery. Pharmaceutics 2023, 15, 419
  3. Markoutsa, E.; Papadia, K.; Giannou, A.D.; Spella, M.; Cagnotto, A.; Salmona, M.; Stathopoulos, G.T.; Antimisiaris, S.G. Mono and Dually Decorated NanoLIPs for Brain Targeting, in vitro and in vivo Studies. Pharm. Res. 2014, 31, 1275–1289.

基金

  1. European Regional Development Fund of the European Union and Greek national funds

补充材料

暂无数据

附加信息

利益冲突
No competing interests were disclosed.
数据可用性声明
The datasets generated during and / or analyzed during the current study are available from the corresponding author on reasonable request.
知识共享许可协议
Copyright © 2023 Kannavou et al. This is an open access work distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
评分
引用
Kannavou, M., Karali, K., Katsila, T., Siapi, E., Marazioti, A., Klepetsanis, P., Calogeropoulou, T., Charalampopoulos, I., Antimisiaris, S. BNN27 nanoformulations for nose-to-brain delivery [not peer reviewed]. Peeref 2023 (poster).
复制引文

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now